Effects of adenosine A3 receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice

European Journal of Pharmacology

Volumn 538, Issue 1-3, 2006, Pages 163-167

  Hofer, Michal ^a   Pospíšil, Milan ^a   Vacek, Antonín ^a   Holá, Jiřina ^a   Znojil, Vladimír ^b   Weiterová, Lenka ^a   Štreitová, Denisa ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

(Mouse); 5 Fluorouracil; Adenosine A3 receptor; Granulopoiesis; Myelosuppression

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR AGONIST; FLUOROURACIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMUR; GRANULOCYTE; GRANULOPOIESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ADENOSINE; ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; FLUOROURACIL; GRANULOCYTES; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; RECEPTOR, ADENOSINE A3; TIME FACTORS;

EID: 33646533751     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.042     Document Type: Article

References (21)

1. Abbracchio M.P. P1 and P2 receptors in cell growth and differentiation. Drug Dev. Res. 39 (1996) 393-406
2. Bar-Yehuda S., Madi L., Barak D., Mittelman M., Ardon E., Ochaion A., Cohn S., and Fishman P. Agonists of the A3 adenosine receptor induce G-CSF production via NF-κB activation: a new class of myeloprotective agents. Exp. Hematol. 30 (2002) 1390-1398
3. Calabrese E.J. Adenosine: biphasic dose responses. Crit. Rev. Toxicol. 31 (2001) 539-551
4. Fishman P., Bar-Yehuda S., Farbstein T., Barer F., and Ohana G. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors. J. Cell. Physiol. 183 (2000) 393-398
5. Fishman P., Bar-Yehuda S., Ohana G., Pathak S., Wasserman L., Barer F., and Multani A.S. Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. Eur. J. Cancer 36 (2000) 1452-1458
6. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., and Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiederberg's Arch. Pharmacol. 363 (2000) 364-374
7. Gessi S., Varani K., Merighi S., Cattabriga E., Iannotta V., Leung E., Baraldi P.G., and Borea P.A. A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol. Pharmacol. 61 (2002) 415-424
8. Harrison D.E., and Lerner C.P. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78 (1991) 1237-1240
9. Hofer M., Pospíšil M., Netíková J., Znojil V., and Vácha J. Enhancement of haemopoietic spleen colony formation by drugs elevating extracellular adenosine: effects of repeated in vivo treatment. Physiol. Res. 46 (1997) 285-290
10. Hofer M., Pospíšil M., Netíková J., Znojil V., and Vácha J. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine act additively to enhance the hemopoietic spleen colony formation in irradiated mice. Physiol. Res. 48 (1999) 37-42
11. Hofer M., Pospíšil M., Znojil V., Vacek A., Weiterová L., Holá J., and Vácha J. Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factor. Eur. J. Haematol. 68 (2002) 4-11
12. Hoferová Z., Hofer M., Pospíšil M., Znojil V., and Chramostová K. Effects of synthetic adenosine receptor agonists on growth characteristics of G:5:113 fibrosarcoma cells in vitro. Drug Dev. Res. 60 (2003) 303-311
13. Moore M.A.S. Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it?. Blood 80 (1992) 3-7
14. Pospíšil M., Hofer M., Znojil V., Vácha J., Netíková J., and Holá J. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood 86 (1995) 3692-3697
15. Pospíšil M., Hofer M., Znojil V., Netíková J., Vácha J., Holá J., and Vacek A. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice. Eur. J. Haematol. 60 (1998) 172-180
16. Pospíšil M., Hofer M., Vacek A., Netíková J., Holá J., Znojil V., and Weiterová L. Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil. Exp. Hematol. 29 (2001) 557-562
17. Pospíšil M., Hofer M., Vacek A., Znojil V., and Pipalová I. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil. Physiol. Res. 53 (2004) 549-556
18. 6-cyclopentyladenosine inhibits proliferation of murine haematopoietic progenitor cells in vivo. Eur. J. Pharmacol. 507 (2005) 1-6
19. Schulte G., and Fredholm B.B. Signalling from adenosine receptors to nitrogen-activated protein kinases. Cell. Signal. 15 (2003) 813-827
20. Trincavelli M.L., Tuscano D., Marroni M., Falleni A., Gremigni V., Ceruti S., Abbracchio M.P., Jacobson K.A., Cattabeni F., and Martini C. A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol. Pharmacol. 62 (2002) 1373-1384
21. 3 adenosine receptor agonist, in healthy young men. Int. J. Clin. Pharmacol. Ther. 42 (2004) 534-542